BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35960373)

  • 1. Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.
    Oliinyk D; Augustin T; Rauch J; Koehler VF; Belka C; Spitzweg C; Käsmann L
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3527-3547. PubMed ID: 35960373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal treatment based on thyroidectomy improves survival in patients with metastatic anaplastic thyroid carcinoma: a SEER analysis from 1998 to 2015.
    Song T; Chen L; Zhang H; Lu Y; Yu K; Zhan W; Fang M
    Gland Surg; 2020 Oct; 9(5):1205-1213. PubMed ID: 33224795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between 1999 and 2012.
    Brignardello E; Palestini N; Felicetti F; Castiglione A; Piovesan A; Gallo M; Freddi M; Ricardi U; Gasparri G; Ciccone G; Arvat E; Boccuzzi G
    Thyroid; 2014 Nov; 24(11):1600-6. PubMed ID: 25110922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
    Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
    Wu SS; Lamarre ED; Yalamanchali A; Brauer PR; Hong H; Reddy CA; Yilmaz E; Woody N; Ku JA; Prendes B; Burkey B; Nasr C; Skugor M; Heiden K; Chute DJ; Knauf JA; Campbell SR; Koyfman SA; Geiger JL; Scharpf J
    JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):300-309. PubMed ID: 36757708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
    Jannin A; Giudici F; de la Fouchardière C; Al Ghuzlan A; Wassermann J; Chougnet CN; Drui D; Godbert Y; Ilouz F; Bardet S; Zanetta S; Roudaut N; Batisse Lignier M; Groussin L; Klein M; Zerdoud S; Lamartina L; Baudin E; Decaussin-Petrucci M; Leteurtre E; Borson Chazot F; Do Cao C; Borget I; Hadoux J;
    Thyroid; 2023 Oct; 33(10):1190-1200. PubMed ID: 37855745
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
    Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
    Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study.
    Zhou W; Yue Y; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():748023. PubMed ID: 34790169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients.
    Busnardo B; Daniele O; Pelizzo MR; Mazzarotto R; Nacamulli D; Devido D; Mian C; Girelli ME
    J Endocrinol Invest; 2000 Dec; 23(11):755-61. PubMed ID: 11194710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.
    Maniakas A; Dadu R; Busaidy NL; Wang JR; Ferrarotto R; Lu C; Williams MD; Gunn GB; Hofmann MC; Cote G; Sperling J; Gross ND; Sturgis EM; Goepfert RP; Lai SY; Cabanillas ME; Zafereo M
    JAMA Oncol; 2020 Sep; 6(9):1397-1404. PubMed ID: 32761153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
    Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
    Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.
    Wendler J; Kroiss M; Gast K; Kreissl MC; Allelein S; Lichtenauer U; Blaser R; Spitzweg C; Fassnacht M; Schott M; Führer D; Tiedje V
    Eur J Endocrinol; 2016 Dec; 175(6):521-529. PubMed ID: 27926471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic thyroid carcinoma: changing trends of treatment strategies and associated overall survival.
    Wächter S; Vorländer C; Schabram J; Mintziras I; Fülber I; Manoharan J; Holzer K; Bartsch DK; Maurer E
    Eur Arch Otorhinolaryngol; 2020 May; 277(5):1507-1514. PubMed ID: 32060602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification in patients with anaplastic thyroid carcinoma: role of age.
    Wang M; Wei T; Gong R; Zhu J; Li Z
    Endocrine; 2022 Aug; 77(2):305-318. PubMed ID: 35608773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component.
    Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
    Endocr Pathol; 2020 Sep; 31(3):283-290. PubMed ID: 32445173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Timeliness of Resection and Thyroidectomy Margin Status on Survival for Patients with Anaplastic Thyroid Cancer: An Analysis of 335 Cases.
    Goffredo P; Thomas SM; Adam MA; Sosa JA; Roman SA
    Ann Surg Oncol; 2015 Dec; 22(13):4166-74. PubMed ID: 26271394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Local Control on Clinical Course in Stage IVC Anaplastic Thyroid Carcinoma.
    Yamazaki H; Sugino K; Katoh R; Masudo K; Matsuzu K; Kitagawa W; Nagahama M; Rino Y; Ito K
    World J Surg; 2022 Dec; 46(12):3034-3042. PubMed ID: 36127501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF
    Zhao X; Wang JR; Dadu R; Busaidy NL; Xu L; Learned KO; Chasen NN; Vu T; Maniakas A; Eguia AA; Diersing J; Gross ND; Goepfert R; Lai SY; Hofmann MC; Ferrarotto R; Lu C; Gunn GB; Spiotto MT; Subbiah V; Williams MD; Cabanillas ME; Zafereo ME
    Thyroid; 2023 Apr; 33(4):484-491. PubMed ID: 36762947
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypofractionated Radiotherapy for Anaplastic Thyroid Cancer: Systematic Review and Pooled Analysis.
    Oliinyk D; Augustin T; Koehler VF; Rauch J; Belka C; Spitzweg C; Käsmann L
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation.
    Zhang K; Wang X; Wei T; Li Z; Zhu J; Chen YW
    Front Endocrinol (Lausanne); 2024; 15():1347362. PubMed ID: 38544687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.